...
首页> 外文期刊>Acta biomaterialia >Nanofibrous PLGA electrospun scaffolds modified with type I collagen influence hepatocyte function and support viability in vitro
【24h】

Nanofibrous PLGA electrospun scaffolds modified with type I collagen influence hepatocyte function and support viability in vitro

机译:用I型胶原蛋白改性纳米纤维PLGA电纺支架影响肝细胞功能和体外载体活力

获取原文
获取原文并翻译 | 示例
           

摘要

A major challenge of maintaining primary hepatocytes in vitro is progressive loss of hepatocyte-specific functions, such as protein synthesis and cytochrome P450 (CYP450) catalytic activity. We developed a three-dimensional (3D) nanofibrous scaffold made from poly(L-lactide-co-glycolide) (PLGA) polymer using a newly optimized wet electrospinning technique that resulted in a highly porous structure that accommodated inclusion of primary human hepatocytes. Extracellular matrix (ECM) proteins (type I collagen or fibronectin) at varying concentrations were chemically linked to electrospun PLGA using amine coupling to develop an in vitro culture system containing the minimal essential ECM components of the liver micro-environment that preserve hepatocyte function in vitro. Cell-laden nanofiber scaffolds were tested in vitro to maintain hepatocyte function over a two-week period. Incorporation of type I collagen onto PLGA scaffolds (PLGA-C-high 100 mu g/mL) led to 10-fold greater albumin secretion, 4-fold higher urea synthesis, and elevated transcription of hepatocyte-specific CYP450 genes (CYP3A4, 3.5-fold increase and CYP2C9, 3-fold increase) in primary human hepatocytes compared to the same cells grown within unmodified PLGA scaffolds over two weeks. These indices, measured using collagen-bonded scaffolds, were also higher than scaffolds coupled to fibronectin or an ECM control sandwich culture composed of type I collagen and Matrigel. Induction of CYP2C9 activity was also higher in these same type I collagen PLGA scaffolds compared to other ECM-modified or unmodified PLGA constructs and was equivalent to the ECM control at 7 days. Together, we demonstrate a minimalist ECM-based 3D synthetic scaffold that accommodates primary human hepatocyte inclusion into the matrix, maintains long-term in vitro survival and stimulates function, which can be attributed to coupling of type I collagen. Published by Elsevier Ltd on behalf of Acta Materialia Inc.
机译:在体外维持原发性肝细胞的主要挑战是肝细胞特异性功能的逐步丧失,例如蛋白质合成和细胞色素P450(CYP450)催化活性。我们通过新优化的湿静电纺丝技术开发了一种由聚(L-丙交酯 - 共乙酰化)(PLGA)聚合物制成的三维(3D)纳米纤维支架,其导致高度多孔结构,该结构容纳掺入原发性人肝细胞。在不同浓度下以不同浓度的细胞外基质(ECM)蛋白(I型胶原或纤连蛋白)使用胺偶联进行化学连接到Electur纺柱PLGA,以开发含有肝脏微环境的最小基本ECM组分的体外培养系统,这些系统在体外保持肝细胞功能。在体外测试细胞 - 载花纳米纤维支架,以在为期两周的时间内保持肝细胞功能。将I型胶原蛋白掺入PLGA支架(PLGA-C-HIGH100μg/ mL),LED为10倍更高的白蛋白分泌,4倍尿素合成,肝细胞特异性CYP450基因的升高转录(CYP3A4,3.5-与在两周内未改性的PLGA支架内的相同细胞相比,原发性人肝细胞中折叠和CYP2C9,3倍,3倍。使用胶原粘连粘结的支架测量的这些索引也高于与纤连蛋白或由I型胶原蛋白和Matrigel组成的ECM控制夹层培养的支架。与其他ECM改性或未修饰的PLGA构建体相比,CYP2C9活性的诱导也较高,其相同的I型胶原蛋白PLGA支架相比,并且在7天内等同于ECM控制。我们一起展示了一种极简主义的ECM的3D合成支架,其将原发性人肝细胞包含到基质中,保持长期的体外存活和刺激功能,其可归因于I型胶原蛋白的偶联。 elsevier有限公司代表Acta Magementia Inc.出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号